INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-13 Cr | ₹1.42 Cr | ₹-4.58 Cr | ₹0.53 Cr | ₹2.91 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDO US BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-13 Cr |
| Mar2025 | ₹1.42 Cr |
| Mar2024 | ₹-4.58 Cr |
| Mar2023 | ₹0.53 Cr |
| Mar2022 | ₹2.91 Cr |
How is Cash Flow from Operating Activities of INDO US BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-13 Cr | Negative | |
| Mar2025 | ₹1.42 Cr | Positive | |
| Mar2024 | ₹-4.58 Cr | Negative | |
| Mar2023 | ₹0.53 Cr | -81.91 | |
| Mar2022 | ₹2.91 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹144.8 Cr | 6% | -6.5% | -52.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,504.0 Cr | -7.6% | -13.1% | -34.4% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,273.1 Cr | -2.5% | -3% | 11.9% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,376.0 Cr | -1.2% | -2.5% | 28.4% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹870.7 Cr | -8.5% | -4.1% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹590.2 Cr | 4.6% | 15.1% | 17.4% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | 6% |
-6.5% |
-52.7% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses